Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01464957 · ClinicalTrials.gov registry record · Phase 2
Skin Cancer Prevention in a Pediatric Population
A Phase 2 study of Skin Cancer, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- Phase 2
- Development phase
- 867
- Enrollment target
- 1
- Study location
NCT01464957: Completed Phase 2 study of Skin Cancer, sponsored by University of Colorado, Denver.
NCT01464957 is a Phase 2 study of Skin Cancer that has completed, run by University of Colorado, Denver. The registered enrollment target is 867 participants, above the 442-participant average among 40 other Skin Cancer trials with a reported enrollment target (96% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01464957, a Phase 2 study of Skin Cancer, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 867 participants
- Enrollment target
- 1
- Study location
Study Summary
Skin cancer risk is largely determined by sun exposure during childhood. This study determines the effectiveness of a mailed intervention designed to increase sun protection for children age 6-9 years old. The intervention includes newsletters for parents that include risk information tailored to each child. Also included are sun protection resources such as a swim shirt, a sun hat, and sunscreen. Participants receive the intervention over 3 consecutive years, and data collection includes telephone interviews and skin exams. The study hypothesis is that receipt of the intervention will result in improved sun protection of the child.
Primary Outcome
Parent report through telephone interview
Conditions Studied
Interventions
- BEHAVIORAL Semi-tailored newsletter
Study Locations (1)
Colorado
- University of Colorado Denver - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 867 participants |
| Start Date | 2003-11 |
| Est. Completion | 2008-09 |
| Phase | Phase 2 |
What the finished NCT01464957 record still lists
NCT01464957 is an interventional study that assigns participants to a tested intervention. The registered 867 participants enrollment target is mid-sized for trials with a published cap, above the 442-participant average among 40 other Skin Cancer trials with a reported enrollment target (96% higher).
The record links to 1 condition, with Skin Cancer appearing as the primary indexed condition, and to 1 intervention - of which Semi-tailored newsletter is the first listed.
NCT01464957 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT01464957 about?
NCT01464957 is a clinical study titled "Skin Cancer Prevention in a Pediatric Population". Skin cancer risk is largely determined by sun exposure during childhood. This study determines the effectiveness of a mailed intervention designed to increase sun protection for children age 6-9 years old. The intervention includes newsletters for parents that include risk information tailored to ea...
What is the current status of trial NCT01464957?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 867 participants. The study started on 2003-11. Estimated completion is 2008-09.
What conditions does trial NCT01464957 study?
This clinical trial studies the following conditions: Skin Cancer.
What interventions are being tested in trial NCT01464957?
The interventions under investigation include: Semi-tailored newsletter (BEHAVIORAL).
Who is sponsoring clinical trial NCT01464957?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01464957 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Skin Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01464957's enrollment target sits among peer trials
867 7th of 40 higher than 34 of 40 other Skin Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Skin Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
TIL Therapy in cSCC and MCC
RECRUITING · Phase 2
-
Cryoablation+Ipilimumab+Nivolumab in Melanoma
RECRUITING · Phase 2
-
Randomized Study of Nivolumab+Ipilimumab+/- SBRT for Metastatic Merkel Cell Carcinoma
ACTIVE NOT RECRUITING · Phase 2
-
A Study of Radiation Therapy and Cemiplimab for People With Skin Cancer
ACTIVE NOT RECRUITING · Phase 2
-
Phase II Study of Radiation Therapy and Vismodegib for Advanced Head/Neck Basal Cell Carcinoma
COMPLETED · Phase 2
-
Study of Talabostat and Cisplatin in Advanced Melanoma
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04933552 · 867 participants
Post-Authorization Safety Study for Assessment of Pregnancy Outcomes in Patients Treated With Mayzent
- NCT06077760 · 868 participants · Phase 3
A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)
- NCT06822790 · 869 participants · Phase 3
Long-Term Safety and Efficacy of Plozasiran in Adults With Hypertriglyceridemia
- NCT05369052 · 865 participants · Phase 3
Safety and Efficacy Study of Contezolid Acefosamil and Contezolid Compared to Linezolid Administered Intravenously and Orally to Adults With Moderate or Severe Diabetic Foot Infections (DFI)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia